期刊文献+

糖皮质激素对结核性胸腔积液T淋巴细胞免疫学特征的影响 被引量:1

Effects of glucocorticoids on the characterization of T-lymphocytic immunology in tuberculous effusion
暂未订购
导出
摘要 目的探讨糖皮质激素对结核性胸腔积液T淋巴细胞特征的影响。方法将肺炎性胸腔积液患者作为对照组;结核性渗出性胸膜炎(简称:结胸)患者随机分为3组,即尚未使用任何药物组(结胸组)、单纯使用抗结核药物组(抗结核组)及抗结核药物联合使用糖皮质激素组(激素组),收集各组的胸腔积液淋巴细胞,体外培养48h后取上清液,采用酶联免疫吸附测定(ELISA)法测定不同T淋巴细胞亚群所分泌相应的细胞因子的水平改变。结果代表辅助T细胞1(Th1细胞)的γ干扰素(IFN-γ)在结胸组水平较对照组明显升高(P<0.01),而代表Th2细胞的白介素-4(IL-4)水平则较对照组有所下降(P<0.05);结核性胸膜炎的治疗过程中,激素组较抗结核组IFN-γ水平明显下降(P<0.01),而IL-4水平变化不明显(P>0.05)。结论结核性胸腔积液T淋巴细胞特征是Th1细胞优势表达,而糖皮质激素可改变这一特征,使Th1细胞优势表达受到抑制。 Objective To evaluate the effects of glucocorticoids on the T-lymphocytic characterization in tuberculous pleural effusion. Methods The lymphocytes in pleural effusion were gotten from pneumonic pleurisy (group N),patients with tuberculous pleurisy before anti-tuberculous therapy (group T),patients after simple anti-tuberculous therapy (group A),and those with anti-tuberculotics plus glucocorticoids therapy (group G) respectively. The above cells were stimulated with phytohemagglutinin(PHA),and the levels of interferon-γ(IFN-γ) secreted by T helper lymphocytes-1(Th1) and interleukin-4 (IL-4) secreted by T helper lymphocytes-2(Th2) in culture supernate of the lymphocytes were determined by ELISA after 48 h. Results The levels of IFN-γ in group T were significantly higher than those of the group N(P<0.01),but the levels of IL-4 were lower than those of the group N(P<0.05),and the levels of IFN-γ in group G were significantly lower than those of the group T(P<0.01),however the changes of the level of IL-4 showed no significant difference between group G and group T (P>0.05). Conclusion Th1 is predominant T-lymphocyte in tuberculous pleural effusion,however this characterization can be controlled by glucocorticoids.
出处 《中国药物与临床》 CAS 2005年第6期433-435,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献5

二级参考文献20

  • 1[1]Boesen H,Jensen B,Wilcke T, et al. [J]. Infect Immun, 1995,63:1491-1497.
  • 2[2]Andersen P. [J]. Infect Imnun, 1994,62:2536-2544.
  • 3[3]Light RW. [M]. Pleural Disease.3rd, Baltimore:Williams & Wilkins,1995: 154-166.
  • 4[4]Lin Y, Zhang M, Florence MH, et al. [J]. Infect Immun, 1996,64:1351-1356.
  • 5[5]Jore MES,Valdes L, Saavedra MJ,et al. [J]. Ann Clin Biochem, 1999,36:492-500.
  • 6[6]Zhang M,Lin Y, Iver DV,et al. [J]. Infect Immun,1995,63: 3231-3234.
  • 7[7]Surcel HM, Troye-Blomberg M, Paulie S, et al. [J].Immunology, 1994,81:171-176.
  • 8[8]Kroegel C,Antony VB. [J]. Eur Respir J,1997,10:7411-7418.
  • 9[9]Cheng DS, Rochignez RM, Perkett EA, et al. [J].Chest, 1999,116(3) :760-765.
  • 10[10]Yamada Y,Nakamura A,Hosoda M,et al. [J]. Respir Med,2001,95(7) :577-581.

共引文献64

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部